Sun, Guangqiang
Wu, Tingfang
Huang, Chengbing
Yu, Mingchao
Guo, Yan
Zhu, Xihua
Yu, Xin
Qiu, Yujia
Article History
Received: 20 September 2022
Accepted: 5 January 2023
First Online: 13 January 2023
Declarations
:
: The study was approved by the Institutional Review Board of Peking University Sixth Hospital (No. 202046). Meanwhile, the informed consent by the WeChat method is approved by the Institutional Review Board of Peking University Sixth Hospital (No. 202046). The Clinical Report Form contained an introduction to the study and informed consent, which stated that the participants joined the study voluntarily. Confidentially was assured. The participants who were not in Beijing verbally agreed to the informed consent by WeChat. No payment was given to the participants for joining this study. All methods were carried out in accordance with relevant guidelines and regulations.
: All the authors gave their consent for publication.
: None of the authors has a conflict of interest.